Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

NCT03955445 ·Status: RECRUITING ·Phase: PHASE3

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386 ·Status: RECRUITING ·Phase: PHASE3

Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study

NCT06614998 ·Status: RECRUITING

Iptacopan in Patients With ANCA Associated Vasculitis

NCT06388941 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430 ·Status: COMPLETED ·Phase: PHASE3

Low-dose Glucocorticoid Vasculitis Induction Study

NCT02198248 ·Status: UNKNOWN ·Phase: PHASE4

Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence

NCT07087314 ·Status: RECRUITING ·Phase: PHASE2

Dupilumab Therapy in Nephrotic Syndrome in Children

NCT07091175 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

NCT05782933 ·Status: UNKNOWN ·Phase: NA

Effect of Tofacitinib in Treating ANCA-associated Vasculitis

NCT04973033 ·Status: COMPLETED ·Phase: NA

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

NCT06983821 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease

NCT05984394 ·Status: RECRUITING

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

NCT00001350 ·Status: RECRUITING

Rituximab in Refractory Primary Membranous Nephropathy

NCT03880643 ·Status: COMPLETED

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

NCT02169219 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

NCT03920722 ·Status: COMPLETED ·Phase: PHASE3

A Study of CCX168 in Japanese and Caucasian Healthy Adult Males

NCT05988008 ·Status: COMPLETED ·Phase: PHASE1

Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.

NCT04585152 ·Status: UNKNOWN ·Phase: PHASE2

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

NCT02592798 ·Status: COMPLETED ·Phase: PHASE2

The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

NCT03531996 ·Status: COMPLETED

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

NCT00013689 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of Two Treatments in the Remission of Vasculitis

NCT00748644 ·Status: COMPLETED ·Phase: PHASE3

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

NCT00059748 ·Status: RECRUITING